anti-CD134(OX40) antibody Augments Teff function

Agonistic humanized anti-CD134(OX40) antibodies improve T effector cell function by depleting T regulatory cells in vitro. This approach has great potential for augmenting cancer therapy!

“Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function” K.S. Voo, Y.J. Liu, et al. (2013) J Immunol 191: 3641-3650. PMID: 24014877

Relevant Ancell Human Products:

anti-CD134(OX40)

anti-CD252(OX40L)

Recombinant CD134(OX40)

Recombinant CD252(OX40L)